Single Shot vs Continuous Interscalene Block for Rotator Cuff Repair

Sponsor
University of Chicago (Other)
Overall Status
Completed
CT.gov ID
NCT01122745
Collaborator
(none)
88
1
38
2.3

Study Details

Study Description

Brief Summary

  1. Rotator cuff have painful post surgery recovery.

  2. Single shot interscalene with oral analgesics may or may not be enough

  3. Continuous nerve block may be too much for the surgery

  4. The idea is to compare two techniques to see if the two techniques can improve patient pain control and satisfaction.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    After consent patients will be randomized to one of the two groups: Control Group or the Experimental Group. Patients will be blinded to the group assignment.

    In the Control Group the patient will be given single shot interscalene block using ultrasound technique following established guidelines. The procedure will be done after starting intravenous access and placing standard anesthesia monitors (EKG, Blood Pressure Cuff and Pulse-Ox) on the patient. Following accepted aseptic guidelines the nerves will be visualized at the base of the neck using ultrasound machine. Once proper nerve roots or trunks visualized 3 mg/kg of 0.5 % bupivacaine will be injected in small blouses.

    In the Experimental Group, after placement of monitors, the nerves will be visualized using ultrasound machine. There after a catheter will be placed. They subjects will be dosed using 0.5% bupivacaine 3 mg/kg for the surgery via the catheter.

    The extent of block before the surgery will be evaluated at 30 minutes post injection. Surgery will be done with sedation. Conversion of anesthetic technique to general anesthesia will be considered failure of the technique to provide adequate surgical anesthesia.

    At the end of the case the patient will be taken to recovery and will be evaluated for pain. If patient is having pain of 3 or more then they will be treated as follows.

    In single shot group will be offered to be blocked again or treated with oral narcotics.

    In the catheter group patient will be dosed with 10 ml 1% lidocaine. If it fails to provide any relief then the catheter will be pulled back and another 10 ml1% lidocaine will be given. If still not effective then it will be replaced. Refusal of patient to replace the catheter will result in patient dropping out of the study.

    Working catheter will be left in place for at least 48 hrs. Patients will be allowed to take oral pain medicines as prescribed by their surgeons. The patient will be sent home with pain pump to continuously give them 0.125% bupivacaine at 5 ml per hr with an option to get extra dose of 5 ml q hr if needed. The pain control will be monitored by phone daily till catheter comes out.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    88 participants
    Time Perspective:
    Prospective
    Official Title:
    Comparison of Pain Relief After Single Shot Interscalene Block With Continuous Interscalene Block for Arthroscopic Rotator Cuff Shoulder Surgery: A Randomized Study
    Study Start Date :
    Aug 1, 2010
    Actual Primary Completion Date :
    Oct 1, 2013
    Actual Study Completion Date :
    Oct 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    Catheter Group

    Patient will have continuous interscalene block for pain relief placed preoperatively. They will go home with the portable pump. Pain score will be tracked via phone and compared with the control or single short group.

    Single shot group

    Patient will have single shot interscalene block and will go home. Pain will be tracked using phone. Pain will be compared with the catheter group.

    Outcome Measures

    Primary Outcome Measures

    1. pain relief [2-3 days]

      Patients having rotator cuff repair surgery will be randomized to either single shot or continuous catheter group. Pain score will be followed for 2 days to see which group gets better pain relief.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • adult

    • rotator cuff surgery

    • agreeing to regional block for pain control

    Exclusion Criteria:
    • pregnancy

    • neuropathy

    • any allergies to local anesthetics

    • any contraindication to nerve blocks

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Chicago Hospitals Chicago Illinois United States 60637

    Sponsors and Collaborators

    • University of Chicago

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Chicago
    ClinicalTrials.gov Identifier:
    NCT01122745
    Other Study ID Numbers:
    • 10-243-B
    First Posted:
    May 13, 2010
    Last Update Posted:
    May 30, 2014
    Last Verified:
    May 1, 2014
    Keywords provided by University of Chicago

    Study Results

    No Results Posted as of May 30, 2014